Literature DB >> 22075379

Understanding the role of cytokines in Glioblastoma Multiforme pathogenesis.

Vivian F Zhu1, Jingxuan Yang, Drake G Lebrun, Min Li.   

Abstract

Cytokines play a significant role in cancer diagnosis, prognosis and therapy. The immune system's failure to recognize the malignant tumor cells and mount an effective response may be the result of tumor-associated cytokine deregulation. Glioblastoma Multiforme (GBM) has a characteristic cytokine expression pattern, and abnormalities in cytokine expression have been implicated in gliomagenesis. Within the heterogeneous GBM microenvironment, the tumor cells, normal brain cells, immune cells, and stem cells interact with each other through the complex cytokine network. This review summarizes the current understanding of the functions of key cytokines on GBM, and highlights potential therapeutic applications targeting these cytokines.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22075379     DOI: 10.1016/j.canlet.2011.11.001

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  57 in total

Review 1.  TET family proteins: new players in gliomas.

Authors:  Er-Bao Bian; Gang Zong; Yong-Sheng Xie; Xiao-Ming Meng; Cheng Huang; Jun Li; Bing Zhao
Journal:  J Neurooncol       Date:  2014-01-07       Impact factor: 4.130

2.  Glioblastoma stem cells are regulated by interleukin-8 signaling in a tumoral perivascular niche.

Authors:  David W Infanger; YouJin Cho; Brina S Lopez; Sunish Mohanan; S Chris Liu; Demirkan Gursel; John A Boockvar; Claudia Fischbach
Journal:  Cancer Res       Date:  2013-10-11       Impact factor: 12.701

Review 3.  TGF-β signaling and its targeting for glioma treatment.

Authors:  Jianfeng Han; Christopher A Alvarez-Breckenridge; Qi-En Wang; Jianhua Yu
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

4.  Laparoscopic surgery for colorectal cancer is not associated with an increase in the circulating levels of several inflammation-related factors.

Authors:  Antonio Crucitti; Maddalena Corbi; Pasquina Mc Tomaiuolo; Caterina Fanali; Andrea Mazzari; Donatella Lucchetti; Mario Migaldi; Alessandro Sgambato
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

5.  Pediatric glioblastoma cells inhibit neurogenesis and promote astrogenesis, phenotypic transformation and migration of human neural progenitor cells within cocultures.

Authors:  Kurt Farrell; Gautam Mahajan; Parthasarathy Srinivasan; Moo-Yeal Lee; Chandrasekhar R Kothapalli
Journal:  Exp Cell Res       Date:  2017-11-10       Impact factor: 3.905

Review 6.  CAR T-cell therapy for glioblastoma: ready for the next round of clinical testing?

Authors:  Brooke L Prinzing; Stephen M Gottschalk; Giedre Krenciute
Journal:  Expert Rev Anticancer Ther       Date:  2018-03-16       Impact factor: 4.512

7.  CXCR2 macromolecular complex in pancreatic cancer: a potential therapeutic target in tumor growth.

Authors:  Shuo Wang; Yanning Wu; Yuning Hou; Xiaoqing Guan; Marcello P Castelvetere; Jacob J Oblak; Sanjeev Banerjee; Theresa M Filtz; Fazlul H Sarkar; Xuequn Chen; Bhanu P Jena; Chunying Li
Journal:  Transl Oncol       Date:  2013-04-01       Impact factor: 4.243

8.  Induced interleukin-33 expression enhances the tumorigenic activity of rat glioma cells.

Authors:  Kuan-Min Fang; Chung-Shi Yang; Tzu-Chien Lin; Ti-Chun Chan; Shun-Fen Tzeng
Journal:  Neuro Oncol       Date:  2013-12-09       Impact factor: 12.300

Review 9.  Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms.

Authors:  Mahmoud Fathy Dondeti; Eman Anwar El-Maadawy; Roba Mohamed Talaat
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

Review 10.  The Dynamics of Interactions Among Immune and Glioblastoma Cells.

Authors:  Katalin Eder; Bernadette Kalman
Journal:  Neuromolecular Med       Date:  2015-07-30       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.